Can Vitamin D Supplementation Reduce Risk of Recurrence of Pneumonia in Under-Five Children?

B. Kiran Kumar,Rakesh Lodha
DOI: https://doi.org/10.1007/s12098-019-03103-2
2019-11-08
The Indian Journal of Pediatrics
Abstract:Pneumonia continues to be an important cause of mortality in under-five children [<span class="CitationRef"><a href="#CR1">1</a></span>]. There has been considerable interest in use of Vitamin D in preventing childhood pneumonia and in improving the outcomes of children with pneumonia. Vitamin D, a fat-soluble vitamin, apart from calcium and phosphate homeostasis, has multiple effects. It modulates innate and acquired immunity and regulates inflammatory cascade. Many of the immune cells express Vitamin D receptors. Vitamin D regulates macrophage and dendritic cell activities and toll like receptor mediated response in neutrophils. Vitamin D induces expression of cathelicidin and β-defensin which have chemotactic and toxin neutralization properties [<span class="CitationRef"><a href="#CR2">2</a></span>]. Association between Vitamin D deficiency and increased risk of pneumonia is well studied [<span class="CitationRef"><a href="#CR3">3</a></span>, <span class="CitationRef"><a href="#CR4">4</a></span>]. Also, association between Vitamin D deficiency and severity of lower respiratory tract infection has been recognized [<span class="CitationRef"><a href="#CR5">5</a></span>]. However, these associations and possible biologic basis for role of preventing and improving treatment outcomes of childhood pneumonia have not been supported by clinical trials.
What problem does this paper attempt to address?